Search Results 101-110 of 14253 for Ischaemic cardiomyopathy
This project uses metabolic reprogramming of donor hearts to improve cardiac performance and ischemic tolerance. Principal investigator: Paul C. Tang, M.D., Ph.
A Study To Evaluate The Influence Of Pulse Electromagnetic Field Therapy On Myocardial Ischemia. Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this ...
The purpose of this study is to prospectively determine if magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIED) ...
The purpose of the ISCHEMIA-CKD trial is to determine the best management strategy for patients with stable ischemic heart disease (SIHD), at least moderate ...
Non-ischemic and ischemic cardiomyopathy with chronic but stable heart failure (NYHA Class II-III) too well for left ventricular assist device (LVAD) implant ...
Subjects must be 18 years of age or older on the day of screening. · Subjects with heart failure or history of heart failure. · Subjects with ischemic or non- ...
Dilated Cardiomyopathy; Heart failure with preserved ejection fraction; Ischemic Cardiomyopathy; Systolic Dysfunction; Tachycardia induced cardiomyopathy ...
Ischemic Cardiomyopathy; Non-ischemic Cardiomyopathy; Invasive hemodynamics; Heart Transplantation; Mechanical circulatory support; Cardiogenic shock; Cardiac ...
Research interests include acute and chronic ischemic heart disease in older adults, heart failure disease management, peripheral vascular disease, and frailty ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.